Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 2, 2013, Pages 154-164

  Deng, Bingmei ^a,b,c   Zhang, Yuhu ^a   Wang, Lijuan ^a   Peng, Kairun ^c   Han, Lixin ^c   Nie, Kun ^a,b   Yang, Hongjun ^c   Zhang, Li ^c   Wang, Jun ^c  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c Liu Hua Qiao Hospital   (China)

Author keywords

cognitive impairment; diffusion tensor imaging; fractional anisotropy; Parkinson's disease; white matter

Indexed keywords

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CORPUS CALLOSUM; CROSS-SECTIONAL STUDY; DEMENTIA; DIFFUSION TENSOR IMAGING; DISEASE DURATION; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; PARKINSON DISEASE; UNIFIED PARKINSON DISEASE RATING SCALE; WHITE MATTER;

EID: 84876584538     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317512470207     Document Type: Article

References (61)

1. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord. 2007 ; 22 (9). 1272-1277
2. Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sørensen P. Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology. 2001 ; 56 (3). 730-736
3. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain. 2007 ; 130 (pt 7). 1787-1798
4. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord. 2008 ; 23 (6). 837-844
5. Levy G, Tang MX, Louis ED, et al. The association of incident dementia with mortality in PD. Neurology. 2002 ; 59 (11). 1708-1713
6. Burn DJ, McKeith IG.. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord. 2003 ; (18 suppl 6). S72 - S79
7. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand. 2004 ; 110 (2). 118-123
8. Dubois B, Burn D, Goetz C, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007 ; 22 (16). 2314-2324
9. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007 ; 22 (12). 1689-1707
10. Minati L, Weglarz WP. Physical foundations, models, and methods of diffusion magnetic resonance imaging of the brain: a review. Concept Magnetic Res A. 2007 ; 30 (5). 278-307
11. Abe O, Aoki S, Hayashi N, et al. Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis. Neurobiol Aging. 2002 ; 23 (3). 433-441
12. Sullivan EV, Pfefferbaum A. Diffusion tensor imaging and aging. Neurosci Biobehav Rev. 2006 ; 30 (6). 749-761
13. Schocke MF, Seppi K, Esterhammer R, et al. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage. 2004 ; 21 (4). 1443-1451
14. Bozzali M, Falini A, Cercignani M, et al. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain. 2005 ; 128 (pt 7). 1595-1604
15. Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol. 1999 ; 20 (8). 1491-1499
16. Dineen RA, Vilisaar J, Hlinka J, et al. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis. Brain. 2009 ; 132 (pt 1). 239-249
17. Sage CA, Van Hecke W, Peeters R, et al. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp. 2009 ; 30 (11). 3657-3675
18. Matsui H, Nishinaka K, Oda M, et al. Depression in Parkinson's disease. Diffusion tensor imaging study. J Neurol. 2007 ; 254 (9). 1170-1173
19. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996 ; 111 (3). 209-219
20. Farina E, Gattellaro G, Pomati S, et al. Researching a differential impairment of frontal functions and explicit memory in early Parkinson's disease. Eur J Neurol. 2000 ; 7 (3). 259-267
21. Uekermann J, Daum I, Peters S, Wiebel B, Przuntek H, Müller T. Depressed mood and executive dysfunction in early Parkinson's disease. Acta Neurol Scand. 2003 ; 107 (5). 341-348
22. Wechsler DW Adult Intelligence Scale. New York, NY: The Psychological Corporation ; 1997:
23. YX G. Chinese version of the Wechsler Adult Intelligence Scale (WAIS-RC). Hunan Maping Press ; 1992:
24. Matsui H, Nishinaka K, Oda M, et al. Wisconsin Card Sorting Test in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand. 2007 ; 116 (2). 108-112
25. Borod JC, Goodglass H, Edith K. Normative AD on the Boston diagnostic aphasia examination, parietal lobe battery and the Boston naming test. J Clin Neuropsychol. 1980 ; 2 (3). 209-216
26. YX G. Chinese revision of the Wechsler Memory Scale. Hunan Maping Press ; 1992:
27. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 ; 56 (3). 303-308
28. Apa D Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association ; 1994:
29. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999 ; 56 (1). 33-39
30. Gattellaro G, Minati L, Grisoli M, et al. White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol. 2009 ; 30 (6). 1222-1226
31. Matsui H, Nishinaka K, Oda M, Niikawa H, Kubori T, Udaka F. Dementia in Parkinson's disease: diffusion tensor imaging. Acta Neurol Scand. 2007 ; 116 (3). 177-181
32. Chui HC, Zarow C, Mack WJ, et al. Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol. 2006 ; 60 (6). 677-687
33. Kuczynski B, Reed B, Mungas D, Weiner M, Chui HC, Jagust W. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease. Arch Neurol. 2008 ; 65 (5). 650-655
34. Levin BE, Katzen HL.. Early cognitive changes and nondementing behavioral abnormalities in Parkinson's disease. Adv Neurol. 1995 ; 65: 85-95
35. Lewis SJ, Foltynie T, Blackwell AD, Robbins TW, Owen AM, Barker RA. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J Neurol Neurosurg Psychiatry. 2005 ; 76 (3). 343-348
36. Owen AM, Sahakian BJ, Hodges JR, et al. Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease. Neuropsychology. 1995 ; 9 (1). 126-140
37. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol. 2003 ; 2 (4). 229-237
38. Beyer MK, Aarsland D, Greve OJ, Larsen JP. Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord. 2006 ; 21 (2). 223-229
39. Lee SJ, Kim JS, Yoo JY, et al. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord. 2010 ; 24 (3). 227-233
40. Choi SA, Evidente VG, Caviness JN, et al. Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?. Acta Neuropathol. 2010 ; 119 (1). 147-149
41. Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005 ; 64 (2). 208-215
42. Marshall GA, Shchelchkov E, Kaufer DI, Ivanco LS, Bohnen NI. White matter hyperintensities and cortical acetylcholinesterase activity in Parkinsonian dementia. Acta Neurol Scand. 2006 ; 113 (2). 87-91
43. Burton EJ, McKeith IG, Burn DJ, Firbank MJ, O'Brien JT. Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am J Geriatr Psychiatry. 2006 ; 14 (10). 842-849
44. Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007 ; 4 (3). 316-329
45. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002 ; 15 (7-8). 435-455
46. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M. Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry. 2004 ; 75 (3). 481-484
47. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P. Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol. 2008 ; 29 (3). 501-505
48. Lee JE, Park HJ, Park B, et al. A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2010 ; 81 (3). 320-326
49. Hattori T, Orimo S, Aoki S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp. 2012 ; 33 (3). 727-739
50. Brück A, Kurki T, Kaasinen V, Vahlberg T, Rinne JO. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson's disease is related to cognitive impairment. J Neurol Neurosurg Psychiatry. 2004 ; 75 (10). 1467-1469
51. Konishi S, Hayashi T, Uchida I, Kikyo H, Takahashi E, Miyashita Y. Hemispheric asymmetry in human lateral prefrontal cortex during cognitive set shifting. Proc Natl Acad Sci U S A. 2002 ; 99 (11). 7803-7808
52. Nagahama Y, Okina T, Suzuki N, Nabatame H, Matsuda M. The cerebral correlates of different types of perseveration in the Wisconsin Card Sorting Test. J Neurol Neurosurg Psychiatry. 2005 ; 76 (2). 169-175
53. Owen AM. Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry. Neuroscientist. 2004 ; 10 (6). 525-537
54. Zgaljardic DJ, Borod JC, Foldi NS, Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol. 2003 ; 16 (4). 193-210
55. Kamagata K, Motoi Y, Abe O, et al. White matter alteration of the cingulum in Parkinson disease with and without dementia: Evaluation by diffusion tensor tract-specific analysis. AJNR Am J Neuroradiol. 2012 ; 33 (5). 890-895
56. Shin J, Choi S, Lee JE, Lee HS, Sohn YH, Lee PH. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status. J Neurol Neurosurg Psychiatry. 2012 ; 83 (3). 315-321
57. Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch Neurol. 2011 ; 68 (12). 1562-1568
58. Camicioli RM, Korzan JR, Foster SL, et al. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett. 2004 ; 354 (3). 177-180
59. Eusebio A, Azulay JP, Witjas T, Rico A, Attarian S. Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulation. Clin Neurophysiol. 2007 ; 118 (4). 815-823
60. Nilsson C, Markenroth Bloch K, Brockstedt S, et al. Tracking the neurodegeneration of parkinsonian disorders - a pilot study. Neuroradiology. 2007 ; 49 (2). 111-119
61. Braak H, Del Tredici K, Rub U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003 ; 24 (2). 197-211